Literature DB >> 11219249

Norplant and other implantable contraceptives.

G Kovalevsky1, K Barnhart.   

Abstract

Implantable contraception represents a safe, reversible form of long-term family planning with distinct advantages. It does not contain estrogen, thus avoiding many of it contraindications. Importantly, it is extremely effective, has high continuation rates, and is well tolerated. The main side effects of Norplant are irregular menstrual bleeding and the occasional difficult removal. Although recent high-profile litigation has severely diminished enthusiasm for Norplant, the FDA has reaffirmed its safety and efficacy. Norplant remains a viable family planning option for carefully selected women. New contraceptive implants may soon be available accentuating the advantages of Norplant while minimizing the disadvantages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11219249     DOI: 10.1097/00003081-200103000-00012

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  2 in total

1.  Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo.

Authors:  Lifei Liu; Liqin Zhao; Hongyun She; Shuhua Chen; Jun Ming Wang; Charisse Wong; Kelsey McClure; Regine Sitruk-Ware; Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2010-10-13       Impact factor: 4.736

2.  Modern Contraceptive Choice Among Patients Seen at the "Cameroon National Planning Association for Family Welfare" Clinic Yaoundé.

Authors:  Tameh Theodore Yangsi; Fouelifack Ymele Florent; Mbong Eta Ngole; Fomulu Nelson
Journal:  Clin Med Insights Reprod Health       Date:  2017-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.